Procreative Autonomy Versus Beneficence in Assisted Reproductive Technologies

Since its beginning, healthcare has focused its attention on helping patients become healthier and live longer. One of the areas in which medical technology has made impressive strides is assisted reproductive technologies. Some bioethical issues are common to most or all of these newer reproductive technologies. The uncertainty of long-term risks posed by reproductive technologies generate potential challenges to the values of beneficence and non-maleficence and strain the already divisive dichotomy between procreative autonomy and procreative beneficence. Procreative autonomy and procreative beneficence are both important values that physicians and prospective parents ought to evaluate when considering the use of assisted reproductive technologies. However, the moral prescriptives associated with each value may diverge and conflict with one another; when this occurs, minute arguments may shift the balance between them. For physicians, prioritizing the value of procreative autonomy or procreative beneficence mainly influences the way in which they choose to present information–that is, whether they are directive or non-directive when consulted about family-planning options. Assisted reproductive technologies have dramatically increased the range of choices available to prospective parents, and this breadth of choice may lead to potential ethical conflicts between the competing values of procreative autonomy and procreative beneficence. In the following article, we will address this friction, focusing our attention on normative considerations related to medical risk management and the telos of the prospective child.